Profil
Lori Elizabeth Mochan is currently a Director at NightstaRx Ltd., Amicus Therapeutics UK Ltd., Nightstar Therapeutics Ltd., and Tungsten Bidco Ltd. She was also a Co-Managing Director at Amicus Therapeutics GmbH.
In the past, she worked as a Director at Amicus Therapeutics International Holding Ltd. from 2018 to 2020.
Postes actifs de Lori Elizabeth Mochan
| Sociétés | Poste | Début |
|---|---|---|
| NIGHTSTAR THERAPEUTICS PLC | Directeur/Membre du Conseil | 21/04/2020 |
Amicus Therapeutics UK Ltd.
Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | 03/05/2018 |
Amicus Therapeutics GmbH
Amicus Therapeutics GmbH BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for rare and orphan diseases | Directeur Général | - |
Tungsten Bidco Ltd.
Tungsten Bidco Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 21/04/2020 |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Directeur/Membre du Conseil | 21/04/2020 |
Anciens postes connus de Lori Elizabeth Mochan
| Sociétés | Poste | Fin |
|---|---|---|
Amicus Therapeutics International Holding Ltd.
Amicus Therapeutics International Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 21/02/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Amicus Therapeutics UK Ltd.
Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Amicus Therapeutics International Holding Ltd.
Amicus Therapeutics International Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Nightstar Therapeutics Ltd.
Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
Amicus Therapeutics GmbH
Amicus Therapeutics GmbH BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for rare and orphan diseases | Health Technology |
Tungsten Bidco Ltd.
Tungsten Bidco Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
















